Navigation Links
China Biopharma Effects 1 for 100 Reverse Stock Split
Date:9/15/2008

HANGZHOU, China, Sept. 15 /PRNewswire-FirstCall/ -- China Biopharma, Inc. (OTC Bulletin Board: CBPC) announced today that it has filed with the Secretary of State of the State of Delaware an amendment to its Certificate of Incorporation to effect a 1 for 100 reverse stock split. China Biopharma's common stock ("Common Stock") will begin trading on a reverse-split basis on September 15, 2008 under the new symbol CHBO.

By unanimous written consent dated July 3, 2008 the Board of Directors adopted an amendment to the Company's Certificate of Incorporation (the "Amendment") to effect a 1 for 100 reverse stock spit of the Company's outstanding Common Stock. The holders of a majority of the outstanding shares of Common Stock by written consent subsequently approved the filing of the Amendment and the reverse split contemplated thereby.

As a result of the reverse stock split, each 100 outstanding shares of Common Stock, par value $.0001 per share will be combined into one share of Common Stock; provided, however, that upon such combination, the Corporation shall not issue fractional shares or pay cash in respect thereof, but shall instead issue to each stockholder the aggregate number of shares resulting from the Reverse Stock Split rounded up to the next higher whole number of shares based upon the preceding calculation. The Reverse Split shall have no effect on the number of authorized shares of Common Stock. The reverse stock split affects all shares of common stock, stock options and warrants of China Biopharma outstanding immediately prior to the effective time of the reverse stock split. China Biopharma's Common Stock currently outstanding is approximately 650 million.

Stockholders who hold their shares in brokerage accounts or "street name" will not be required to take any action to effect the exchange of their shares. Stockholders of record who hold share certificates will receive a letter of transmittal requesting that they surrender th
'/>"/>

SOURCE China Biopharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
2. China Yingxia International, Inc. Appoints New Vice President of Finance
3. China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility
4. China Biologic Products to Present at the SIG Beijing Management Summit
5. China Biologics Production Facility Renews GMP Certification
6. China Bio Energy Holdings Group Announces Participation in the Susquehanna Second Annual Beijing Management Summit
7. Plexus Announces Expansion in Hangzhou, China
8. China Sky One Medical, Inc. Approved to List on the NASDAQ Global Market
9. China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) Beijing Management Summit
10. ORBIS and Alcon Train Chinas Next Generation of Sight-Savers
11. China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... OAK RIDGE, Tenn., July 24, 2014 -- A novel ... at the Department of Energy,s Oak Ridge National Laboratory ... known for its unusual physical and electrochemical properties. ... examined how oxygen affects the surface of a perovskite ... electronic behavior. The new avenue to understand surface behavior ...
(Date:7/24/2014)... sophisticated equipment, trained personnel, and detection dogs to ... attacks. A revolutionary new electronic chip with nano-sized ... much easier. , The groundbreaking nanotechnology-inspired sensor, devised ... ,s School of Chemistry and Center for Nanoscience ... Tracense, picks up the scent of explosives molecules ...
(Date:7/24/2014)... 2014 Research and Markets has ... Market 2014-2018" report to their offering.  ... is the in vitro growth of plant or animal ... and biopharmaceutical production. Cell culture is a crucial step ... and cell culture consumables are necessary for the in ...
(Date:7/24/2014)... Three companies from the angelMD network were ... Competition. Out of 700 competition entrants, Chiron Health, Litesprite, ... round. In this round twenty teams are invited to ... mentoring from thought-leaders and medical entrepreneurs from all over ... commitment to the Livestrong vision around the Big C ...
Breaking Biology Technology:ORNL study reveals new characteristics of complex oxide surfaces 2Nano-sized chip 'sniffs out' explosives far better than trained dogs 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
... ANTONIO, March 30 BioMedical Enterprises, Inc. (BME), a ... development of orthopaedic memory metal implants, announced today that ... President, Sales and Marketing. BME specializes in nitinol ... bone ends together to promote bone union. The ...
... DIEGO, CA, March 30, 2009 Senomyx, Inc. (Nasdaq: ... using proprietary technologies to discover and develop novel flavor ... announced today the extension of the collaborative research phase ... Campbell Soup Company, a global manufacturer and marketer of ...
... final study data to FDA for cervical cancer vaccinePHILADELPHIA ... GSK ) today provided the following update regarding its ... for approval of CERVARIX(R), its vaccine to prevent cervical ... 16 and 18.GSK has submitted final data from its ...
Cached Biology Technology:BioMedical Enterprises, Inc. (BME) Announces the Appointment of Keith M. Peeples as Vice President, Sales and Marketing 2SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY 2SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY 3CERVARIX(R) U.S. Regulatory Update 2CERVARIX(R) U.S. Regulatory Update 3
(Date:7/25/2014)... 2014)The link between autism and disrupted brain development ... the disease, and is largely unknown. However, thanks ... Initiative (SFARI), George Washington University (GW) researcher Anthony-Samuel ... integrative and in-depth answers to these key questions ... LaMantia, professor of pharmacology and physiology at the ...
(Date:7/25/2014)... increasingly consume the healthcare community and remain ... , To address the worldwide crisis of ... countries, global leaders in diabetes, epidemiology and ... prevention and development of diverse intervention programs ... , This book on "Global Health Perspectives ...
(Date:7/25/2014)... tractography (DTT), which is derived from diffusion tensor ... motor tracts, such as the corticospinal tract, the ... The corticospinal tract is known to be a ... human brain. Several studies have reported on injury ... addition, some studies have demonstrated recovery of a ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2What constitutes an effective response to the global 'diabesity' tsunami? 2
... less than two weeks, Amanda Cobbs-Russell, a junior majoring in ... the adventure of a lifetime, requiring her to push herself ... of only five people two Americans and three Canadians ... to hike, eat, and sleep among sweeping glaciers, polar ice ...
... American Society for Microbiology (ASM) ICAAC Young Investigator Award ... College London. Sponsored by the ASM, this award ... and infectious diseases. Dr. Grndling,s initial work focused ... the membrane and how S monomers interact. She constructed ...
... state of upheaval, it is expected that they might take refuge ... milkshake? Not so, says Stacy L. Wood, Associate ... South Carolina. In fact, in a study to be published ... when people are in a state of upheaval, they,re more likely ...
Cached Biology News:UC Riverside student is 1 of only 5 persons selected for challenging Arctic expedition 2UC Riverside student is 1 of only 5 persons selected for challenging Arctic expedition 3
... NaCl, 20mM MOPS, pH 7.5, 60mM ... EGTA, 10 Properites: For selective in ... chromatography, divalent cation activation plus trypsin ... Assurance: routinely evaluated by dephosphorylation of ...
Mouse monoclonal [6G11] to Cytohesin 1 + 2 ( Abpromise for all tested applications)....
HNF-1 Purified Anti-Mouse, Anti-Rat, Anti-Rabbit, Anti-Human clone 2, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Recombinant Porcine IL-1 alpha/IL-1F1, CF...
Biology Products: